| Ytd | -2.88% | |
| 1y | 14.47% |
| Open | 47.01 | Prev Close | 47.15 | Low | 46.72 | High | 48.40 | Mkt Cap | 2.80B |
| Vol | 297.57K | Avg Vol | 860.69K | EPS | 3.06 | P/E | 15.77 | Forward P/E | 10.82 |
| Beta | 0.56 | Short Ratio | 6.55 | Inst. Own | 104.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 46.32 | 200-d Avg | 48.84 | 1yr Est | 61.75 |
SUPN News
Assenagon Asset Management S.A. lessened its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ: SUP
California State Teachers Retirement System lifted its stake in Supernus Pharmaceuticals, Inc. (NASD
The most oversold health care stocks present a buying opportunity. RSI indicator compares stock stre
Supernus and Indivior agree to merge in an all-stock deal, targeting $2.2 billion in revenue and $12
Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly earnings of $0.53 per share which beat the
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday'
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) and Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today
During Wednesday's morning session, 226 stocks hit new 52-week highs.
This morning 533 companies reached new 52-week highs.
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Friday
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018